About Glendale Biomed
Glendale Biomed is a Healthcare company based in Mumbai (India) founded in 2016. A pharmaceutical company providing a diverse range of products for domestic distribution. It operates on a B2B model. Its Indian entity Glendale Biomed Private Limited reported revenue of ₹30.54 Cr. Its focus areas include Pharmaceuticals, Drug Manufacturing and Distribution. Similar companies include Entero Healthcare, Keimed and Sandor Medicaids; 3 of its 3 listed similar companies have raised funding.
Company details
Glendale Biomed, based in Mumbai, focuses on providing healthcare solutions, producing pharmaceutical products, drug manufacturing, and distribution. A pharmaceutical company providing a diverse range of products for domestic distribution. The company prioritizes operational excellence, innovation, and customer-centric approaches for success.
- Headquarters Mumbai, India
- SectorsHealthcare
- Website glendalebiomed.com
- Legal Name Glendale Biomed Private Limited
- Date of Incorporation 04 Mar, 2016
- Jurisdiction Mumbai, Maharashtra, India
- Annual Revenue₹30.54 Cr
FY 2023 · +51% YoY
- Net Profit₹1.30 Cr
FY 2023 · 4% margin
- EBITDA₹2.79 Cr
FY 2023 · 9% margin
Associated legal entities of Glendale Biomed
Glendale Biomed operates through Glendale Biomed Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2023) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Glendale Biomed Private Limited CIN U74120MH2016PTC273873 | Active | 04 Mar 2016 | Mumbai, Maharashtra | ₹30.5 Cr | 2 | View details |
Board of directors of Glendale Biomed Private Limited (Glendale Biomed)
Glendale Biomed Private Limited is the primary company behind Glendale Biomed. The board of Glendale Biomed Private Limited currently have 2 directors; the longest-serving is Pramod Yadav, appointed in 2017. 6 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Pramod Yadav DIN 07371684 | Director | 15 Dec 2017 | 8 yrs 10 mo | Glendale Biomed Private Limited |
| Suraj Prakash Singh DIN 08263116 | Additional Director | 20 Apr 2020 | 6 yrs 6 mo | Glendale Biomed Private Limited |
Financials of Glendale Biomed
Figures of Glendale Biomed Private Limited, the primary company behind Glendale Biomed, for FY 2023. Revenue was ₹30.54 Cr (+51% year on year). Net profit was ₹1.30 Cr (4% margin). EBITDA was ₹2.79 Cr (9% margin). Revenue has grown at a compounded annual rate of +30% over three years and +19% over five years.
- ₹30.54 CrRevenue · FY 2023 · +51% YoY
- ₹1.30 CrNet profit · 4% margin
- ₹2.79 CrEBITDA · 9% margin
- ₹2.20 CrPaid-up capital
- +30%Revenue CAGR, 3 years
- +19%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Glendale Biomed Private Limited are on its company page.
Detailed financial statements for Glendale Biomed
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Similar companies to Glendale Biomed
Glendale Biomed has 3 listed similar companies in our database, 3 of them funded. They include Entero Healthcare, Keimed and Sandor Medicaids.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| enterohealthcare.com | 2018 | Mumbai, India | $59.67M | 817 | India's leading healthcare products distribution platform | |
| keimed.com | 2000 | Hyderabad, India | $16.62M | 588 | Temperature-sensitive medicines are distributed via cold chain logistics by Keimed. | |
| sandor.co.in | 1995 | Hyderabad, India | $8.98M | 161 | Provider of medical equipment, devices, and drugs distribution services |
Detailed similar companies of Glendale Biomed
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Glendale Biomed
Glendale Biomed was founded in 2016.
Glendale Biomed is headquartered in Mumbai, India. It is registered at Mumbai, Maharashtra, India.
The primary company behind Glendale Biomed, Glendale Biomed Private Limited, reported revenue of ₹30.54 Cr for FY 2023, up 51% year on year.
Glendale Biomed, based in Mumbai, focuses on providing healthcare solutions, producing pharmaceutical products, drug manufacturing, and distribution. A pharmaceutical company providing a diverse range of products for domestic distribution. The company prioritizes operational excellence, innovation, and customer-centric approaches for success.
Glendale Biomed's top competitors include Entero Healthcare, Keimed and Sandor Medicaids.
Glendale Biomed operates through Glendale Biomed Private Limited.
The legal entities of Glendale Biomed currently have 2 directors, including Suraj Prakash Singh, Pramod Yadav.